Feliza Mirasol

Feliza Mirasol is the science editor for BioPharm International.


Shining a Spotlight on Nucleic Acid-Based Therapeutics

Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.

Emerging Plant-based Platform for Biomanufacturing

Plant-based manufacturing technology gains mainstream edge in biopharmaceutical production.

Regenerative Medicines Development Activity Spikes on Back of Focused Investments

A rise in investments and funding into regenerative medicines projects has helped to advance a rich clinical pipeline.

Insights into Outsourced vs. In-house Clinical Trial Services

Capacity concerns and regulatory compliance considerations will drive the decision about outsourcing the manufacture of clinical trial materials.